David Palma, MD, PhD @drdavidpalma

Radiation Oncologist | Researcher | Marathon runner and triathlete | Dad x 3 | Author, Taking Charge of Cancer Joined June 2025

Tweets

94
Followers

858
Following

214
Likes

74

Sue Yom @sueyom

a day ago

JOB ALERT! At UCSF we have one of the most collegial HN groups around. If you're a #radonc who'd like to be a part of it, send us a cover letter and CV! We'd love to meet some people during ASTRO!

0 10 37 3K 1

Shankar Siva @_ShankarSiva

2 days ago

📣 Great news!!! The @PeterMacCC SABR symposium program is finalised 😁 sabrsymposium.com/program-2025 A fantastic ⭐️ international faculty @PBlanchardMD @lauren_henke @BarbaraJereczek @DrewMoghanaki @Melissa_O_Neil Hope to see you there! @PeterMacRadOnc

2 7 46 3K 2

Pierre Blanchard, MD @PBlanchardMD

3 days ago

Another proof that metastasis directed therapy improves outcomes, this time in castration resistant #prostatecancer Congrats to the PCS IX team! author link at @TheLancetOncol: authors.elsevier.com/a/1liJQ5EIIgTS…

2 80 203 12K 72

Download Image

David Palma, MD, PhD @drdavidpalma

2 days ago

🤔A common exam question: We saw this patient in our resident-led new-patient clinic...which lobe is this tumor in?

2 0 15 2K 5

Download Image

David Palma, MD, PhD @drdavidpalma

a week ago

H+N oncologists: anyone seeing high rates of severe skin toxicity with RT + concurrent docetaxel (15 mg/m2)? Some of the skin reactions are the worst I've seen. Wondering if this is a cetuximab moment. I'd post some photos but they aren't great for social media.

7 9 42 4K 9

Download Image

David Palma, MD, PhD @drdavidpalma

2 weeks ago

Interesting case report in the Green Journal showing lung function changes after SBRT - you can see how the contralateral lung compensates. A similar effect was shown for locally advanced disease previously by Grace Parraga's team. #sparetheotherlung

1 24 80 5K 32

Download Image

David Palma, MD, PhD @drdavidpalma

2 weeks ago

Here's a patient recently randomized on our ARREST2 phase 2/3 RCT. Sixteen pulmonary mets, 35 Gy in 5 fractions. Constraints: V13.5 Gy <37%, 1500 cc of lung <12.5 Gy

14 53 205 14K 56

Download Video

Andrew Thomson @Thomson416

4 weeks ago

If here was ever a time for Canada to find some actual cash for R&D, it would be now … As the Americans step back, it’s time for Canada to step up.

Acyn @Acyn

a month ago

If here was ever a time for Canada to find some actual cash for R&D, it would be now … As the Americans step back, it’s time for Canada to step up.

3K 1K 7K 13.6M 2K

Download Video

173 236 1K 42K 5

David Palma, MD, PhD @drdavidpalma

4 weeks ago

“Snowman sign”in NEJM this week - a classic rad onc exam question! nejm.org/image-challeng…

1 6 59 4K 10

Download Image

David Palma, MD, PhD @drdavidpalma

4 weeks ago

Important re-irradiation lesson for #radonc residents: when you look at your DVH in EQD2 (like in MIM), the "V20" that you need to look at will change. Here's a DVH from a 60/30 plan shown as physical dose vs. EQD2. The DVH looks much better below 60 Gy & a bit worse above it.

David Palma, MD, PhD @drdavidpalma

4 weeks ago

1 10 65 10K 39

Download Image

1 22 78 7K 56

Download Image

David Palma, MD, PhD @drdavidpalma

4 weeks ago

Here's another REPAIR case. Previous contralateral 60 Gy/30, 36% repair allowed, now getting 60 Gy/8. You can see how the PTV (red line) and IGTV (yellow) are compromised medially to meet OAR constraints. We use MIM to get EQD2 composites and this nice scoresheet. 😀

1 10 65 10K 39

Download Image

Alexander Sherry @AlexSherryMD

a month ago

Does the addition of MDT to standard of care continuous ADT improve outcomes for oligomet prostate ca? Happy to share the results of EXTEND evaluating this question alongside PI @ChadTangMD & many others